Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Dec 9, 2011

New Genome Center to Bring Sequencing, Bioinformatics Muscle to Big Apple

Fearing that the city has fallen behind in biotech, 11 academic medical centers joined forces to form the $125 million New York Genome Center.

New Genome Center to Bring Sequencing, Bioinformatics Muscle to Big Apple

The NYGC’s ultimate goal is to develop a biotech cluster in New York that rivals those of Boston and San Francisco. [© dell - Fotolia.com]

  • If New York City is ever to become a top-tier biopharma cluster, the $125 million New York Genome Center (NYGC) set to start operations ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »